Status | Study |
Completed |
Study Name: Weight Gain in Surgically Treated Adult-onset Craniopharyngioma Condition: Adult-onset Craniopharyngioma Postoperative Weight Gain Date: 2013-10-20 |
Recruiting |
Study Name: Peginterferon Alfa-2b in Treating Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery Condition: Childhood Craniopharyngioma Date: 2013-10-14 Interventions: Biological: peginterferon alfa-2b |
Completed |
Study Name: Sleep Wake and Melatonin Pattern in Craniopharyngioma Condition: Sleep Disorders, Circadian Rhythm Craniopharyngioma Date: 2013-06-12 |
Completed |
Study Name: Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor Condition: Obesity Overweight Craniopharyngioma Date: 2011-10-20 Interventions: Drug: Exenatide Treatment with exenatide 5 mcg twice daily for 4 weeks, then 10 mcg twice daily for 46 w |
Active, not recruiting |
Study Name: A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection Condition: Craniopharyngioma Date: 2011-08-16 Interventions: Procedure: Radical Surgery or Limited Surgery |
Recruiting |
Study Name: Prospective Study of Children and Adolescents With Craniopharyngioma Condition: Craniopharyngioma Obesity Date: 2011-01-07 Interventions: Radiation: Radiation Immediate |
Completed |
Study Name: 1.5T Intraoperative MR Imaging in Craniopharyngiomas Condition: Craniopharyngioma Date: 2010-09-20 Interventions: Other: Intraoperative imaging using 1.5T MRI Intraoperative imaging and determination of degree of resec |
Completed |
Study Name: RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma Condition: Acoustic Schwannoma Adult Anaplastic (Malignant) Meningioma Date: 2010-05-06 Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy |
Terminated |
Study Name: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Choriocarcinoma Date: 2010-03-16 Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097 |
Completed |
Study Name: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Choriocarcinoma Date: 2010-02-25 Interventions: Drug: vorinostat Other Names: |